Group One Trading
ANRO icon

Group One Trading’s Alto Neuroscience ANRO Stock Holding History

Group One Trading’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.99K Sell
400
-1,013
-72% -$18.8K ﹤0.01% 6425
2025
Q4 		$25.2K Sell
1,413
-1,245
-47% -$15.7K ﹤0.01% 6182
2025
Q3 		$10.7K Buy
2,658
+1,833
+222% +$6.08K ﹤0.01% 7124
2025
Q2 		$1.81K Buy
825
+334
+68% +$795 ﹤0.01% 7436
2025
Q1 		$1.06K Buy
+491
New +$1.76K ﹤0.01% 7160

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading's ANRO Position: Q1 2026 in Review

Group One Trading reduced its Alto Neuroscience (ANRO) stake by 72% in Q1 2026, selling an estimated $18.8K and leaving 400 shares worth $8.99K. The position accounts for ﹤0.01% of the portfolio, ranked #6425.

Group One Trading first reported a position in ANRO in Q1 2025 and has held it in 5 quarters since. The position peaked at $25.2K in Q4 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Group One Trading held 400 shares of Alto Neuroscience worth $8.99K as of Q1 2026.
  • Group One Trading sold 1,013 Alto Neuroscience shares in Q1 2026, an estimated $18.8K.
  • Alto Neuroscience made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6425 holding.
  • Group One Trading first reported a position in Alto Neuroscience in Q1 2025 and has held it in 5 quarters since.
  • Group One Trading's Alto Neuroscience position peaked at $25.2K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.